Related Experiment Video
Updated: Jun 17, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Chemotherapy for colorectal cancer]
1Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|December 23, 2009
Summary
Colorectal cancer treatment has advanced with new chemotherapy drugs like oxaliplatin and targeted therapies. Treatment choice depends on cancer stage, biology, and patient characteristics for optimal survival outcomes.
Area of Science:
- Oncology
- Medical Chemistry
Background:
- Colorectal cancer (CRC) treatment has evolved significantly with chemotherapy and targeted agents.
- 5-fluorouracil (5-FU) remains a cornerstone, but newer agents like irinotecan, oxaliplatin, bevacizumab, and cetuximab have altered strategies.
Purpose of the Study:
- To review and organize current standard chemotherapy strategies for colorectal cancer.
- To provide an overview based on recent pivotal publications.
Main Methods:
- Literature review of pivotal publications on colorectal cancer chemotherapy.
- Analysis of treatment strategies for both adjuvant and metastatic settings.
Main Results:
- Oxaliplatin plus 5-FU shows improved disease-free and overall survival over 5-FU alone in adjuvant colon cancer therapy.
- Treatment benefits vary based on postoperative stage, tumor biology, and clinical factors.
- Targeted agents like bevacizumab and cetuximab are crucial in metastatic CRC, with ongoing research for predictive biomarkers.
Conclusions:
- Adjuvant chemotherapy decisions for colorectal cancer require careful consideration due to complexity.
- Treatment strategies for metastatic colorectal cancer are more intricate, utilizing a broader range of agents.
- Identifying biomarkers for targeted therapy response is a key area of ongoing research.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...